Insider Selling: Marsh & McLennan Companies, Inc. (NYSE:MMC) Director Sells $1,254,060.00 in Stock

Marsh & McLennan Companies, Inc. (NYSE:MMCGet Free Report) Director Oscar Fanjul sold 6,000 shares of the company’s stock in a transaction that occurred on Thursday, June 13th. The shares were sold at an average price of $209.01, for a total value of $1,254,060.00. Following the transaction, the director now directly owns 53,393 shares in the company, valued at approximately $11,159,670.93. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

Marsh & McLennan Companies Price Performance

MMC opened at $212.72 on Thursday. The firm has a market capitalization of $104.81 billion, a PE ratio of 26.99, a price-to-earnings-growth ratio of 3.00 and a beta of 0.93. The business’s 50-day moving average is $204.92 and its two-hundred day moving average is $200.43. Marsh & McLennan Companies, Inc. has a 1 year low of $179.35 and a 1 year high of $213.21. The company has a debt-to-equity ratio of 0.97, a current ratio of 1.14 and a quick ratio of 1.14.

Marsh & McLennan Companies (NYSE:MMCGet Free Report) last posted its quarterly earnings data on Thursday, April 18th. The financial services provider reported $2.89 EPS for the quarter, topping the consensus estimate of $2.80 by $0.09. Marsh & McLennan Companies had a net margin of 16.84% and a return on equity of 34.14%. The firm had revenue of $6.50 billion during the quarter, compared to analyst estimates of $6.38 billion. During the same quarter in the previous year, the business posted $2.53 EPS. Marsh & McLennan Companies’s revenue was up 9.7% on a year-over-year basis. Research analysts anticipate that Marsh & McLennan Companies, Inc. will post 8.68 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Marsh & McLennan Companies

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Norges Bank acquired a new stake in Marsh & McLennan Companies in the 4th quarter worth approximately $1,048,077,000. Price T Rowe Associates Inc. MD grew its holdings in shares of Marsh & McLennan Companies by 32.7% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 10,243,245 shares of the financial services provider’s stock valued at $1,940,789,000 after buying an additional 2,526,701 shares during the last quarter. Impax Asset Management Group plc purchased a new position in Marsh & McLennan Companies in the 4th quarter worth $261,787,000. Jennison Associates LLC lifted its position in Marsh & McLennan Companies by 229.6% during the 1st quarter. Jennison Associates LLC now owns 932,452 shares of the financial services provider’s stock worth $192,066,000 after acquiring an additional 649,505 shares during the period. Finally, Corient Private Wealth LLC grew its stake in Marsh & McLennan Companies by 322.7% during the 4th quarter. Corient Private Wealth LLC now owns 761,238 shares of the financial services provider’s stock valued at $144,232,000 after purchasing an additional 581,131 shares during the last quarter. 87.99% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several brokerages have commented on MMC. Piper Sandler downgraded Marsh & McLennan Companies from an “overweight” rating to a “neutral” rating and set a $211.00 price objective on the stock. in a research report on Wednesday, April 17th. TD Cowen raised their price target on shares of Marsh & McLennan Companies from $189.00 to $201.00 and gave the stock a “hold” rating in a research note on Monday, April 22nd. Bank of America upped their target price on shares of Marsh & McLennan Companies from $223.00 to $233.00 and gave the stock a “neutral” rating in a research note on Wednesday, May 22nd. JPMorgan Chase & Co. lifted their price target on shares of Marsh & McLennan Companies from $190.00 to $198.00 and gave the company a “neutral” rating in a research note on Monday, April 8th. Finally, Morgan Stanley increased their price objective on Marsh & McLennan Companies from $205.00 to $210.00 and gave the stock an “equal weight” rating in a research note on Monday, April 15th. Two investment analysts have rated the stock with a sell rating, ten have given a hold rating and four have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus target price of $210.27.

Check Out Our Latest Report on Marsh & McLennan Companies

Marsh & McLennan Companies Company Profile

(Get Free Report)

Marsh & McLennan Companies, Inc, a professional services company, provides advice and solutions to clients in the areas of risk, strategy, and people worldwide. It operates through Risk and Insurance Services, and Consulting segments. The Risk and Insurance Services segment offers risk management services, such as risk advice, risk transfer, and risk control and mitigation solutions, as well as insurance and reinsurance broking, strategic advisory services, and analytics solutions, and insurance program management services.

Featured Stories

Insider Buying and Selling by Quarter for Marsh & McLennan Companies (NYSE:MMC)

Receive News & Ratings for Marsh & McLennan Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Marsh & McLennan Companies and related companies with MarketBeat.com's FREE daily email newsletter.